Koyfin Home > Directory > Health Care > Akebia Therapeutics > Total Equity

Akebia Therapeutics Total Equity Chart (AKBA)

Akebia Therapeutics annual/quarterly Total Equity from 2012 to 2020.
  • Akebia Therapeutics Total Equity for the quarter ending June 06, 2020 was $370m a -26.28% decrease of -97m year over year
  • Akebia Therapeutics Total Equity for the last 12 months ending June 06, 2020 was $370m a -26.28% decrease of -97m year over year
  • Akebia Therapeutics Annual Total Equity for 2019 was $395m a -61.09% decrease of -241m from 2018
  • Akebia Therapeutics Annual Total Equity for 2018 was $636m a 80.73% increase of 513m from 2017
  • Akebia Therapeutics Annual Total Equity for 2017 was $123m a 44.43% increase of 54m from 2016
Other Balance Sheet Metrics:
  • Akebia Therapeutics Total Assets for the quarter ending December 12, 2018 was $997m a 55.57% increase of 554m year over year
  • Akebia Therapeutics Other Liabilities for the quarter ending December 12, 2018 was $95m a 0.76% increase of 1m year over year
View Chart On Koyfin

Quarterly AKBA Total Equity Data

06/2020$370m
03/2020$396m
12/2019$395m
09/2019$468m
06/2019$519m
03/2019$566m
12/2018$636m
09/2018$143m
06/2018$166m
03/2018$197m

Annual AKBA Total Equity Data

2019$395m
2018$636m
2017$123m
2016$68m
2015$131m
2014$104m
2013$31m
2012$1m
2011$5m